BIOMAT Database Logo BIOMAT Database Logo

Physiologic and antibiotic (penicillin) therapy in chronic hypertrophic pulmonary emphysema. 1947

A L BARACH, and B GARTHWAITE

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011656 Pulmonary Emphysema Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions. Emphysema, Pulmonary,Centriacinar Emphysema,Centrilobular Emphysema,Emphysemas, Pulmonary,Focal Emphysema,Panacinar Emphysema,Panlobular Emphysema,Pulmonary Emphysemas,Centriacinar Emphysemas,Centrilobular Emphysemas,Emphysema, Centriacinar,Emphysema, Centrilobular,Emphysema, Focal,Emphysema, Panacinar,Emphysema, Panlobular,Emphysemas, Centriacinar,Emphysemas, Centrilobular,Emphysemas, Focal,Emphysemas, Panacinar,Emphysemas, Panlobular,Focal Emphysemas,Panacinar Emphysemas,Panlobular Emphysemas
D004646 Emphysema A pathological accumulation of air in tissues or organs.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

A L BARACH, and B GARTHWAITE
Physiologic factors in the treatment of chronic hypertrophic pulmonary emphysema.
February 1952, Annals of internal medicine,
A L BARACH, and B GARTHWAITE
Physiologic considerations in the therapy of chronic pulmonary emphysema.
July 1956, Southern medical journal,
A L BARACH, and B GARTHWAITE
Physiologic basis for rational therapy in chronic pulmonary emphysema.
April 1956, Postgraduate medicine,
A L BARACH, and B GARTHWAITE
Physiologic therapy of chronic bronchitis and emphysema.
September 1966, Physiology & pharmacology for physicians,
A L BARACH, and B GARTHWAITE
A study of pulmonary hypertension in chronic hypertrophic pulmonary emphysema.
November 1948, The Journal of laboratory and clinical medicine,
A L BARACH, and B GARTHWAITE
Pulmonary emphysema: physiologic factors in diagnosis and advances in therapy.
May 1955, Journal of the American Geriatrics Society,
A L BARACH, and B GARTHWAITE
HYPERTROPHIC pulmonary emphysema.
January 1956, Lancet (London, England),
A L BARACH, and B GARTHWAITE
Chronic hypertrophic emphysema.
January 1955, GP,
A L BARACH, and B GARTHWAITE
Localized pulmonary hypertrophic emphysema.
November 1952, The Journal of thoracic surgery,
A L BARACH, and B GARTHWAITE
Localized pulmonary hypertrophic emphysema.
November 1953, Virginia medical monthly,
Copied contents to your clipboard!